Position in RVMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,798,200
+$24,727,919 QoQ
Shares Held
244,544
+12.9% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#93
of 685 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
280,521
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. RVMD ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in RVMD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,798,200 | 244,544 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $21,070,281 | 216,661 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $30,760,112 | 386,191 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $7,523,182 | 161,096 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,018,383 | 27,681 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $6,618,967 | 187,188 | Shares | Other | 2025-05-15 | |
| 2024-12-31 RVMDW | — | 280,521 | Call | Other | 2025-02-13 | |
| 2024-12-31 | $65,819,995 | 1,504,801 | Shares | Other | 2025-02-13 | |
| 2024-09-30 RVMDW | — | 485,000 | Call | Other | 2024-11-14 | |
| 2024-09-30 | $48,297,704 | 1,064,999 | Shares | Other | 2024-11-14 | |
| 2024-06-30 RVMDW | — | 500,000 | Call | Other | 2024-08-14 | |
| 2024-06-30 | $31,671,094 | 816,055 | Shares | Other | 2024-08-14 | |
| 2024-03-31 RVMDW | — | 502,947 | Call | Other | 2024-05-15 | |
| 2024-03-31 | $49,503,346 | 1,535,940 | Shares | Other | 2024-05-15 | |
| 2023-12-31 RVMDW | — | 502,947 | Call | Other | 2024-02-14 | |
| 2023-12-31 | $34,672,083 | 1,208,929 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $2,382,915 | 86,088 | Shares | Other | 2023-11-14 | |
| 2022-03-31 | $4,005,197 | 157,005 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $25,899 | 1,029 | Shares | Other | 2022-02-14 | |
| 2021-06-30 | $1,111,883 | 35,031 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||